Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Gilead Sciences Total Assets 2006-2020 | GILD

Gilead Sciences total assets from 2006 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Gilead Sciences total assets for the quarter ending June 30, 2020 were $55.934B, a 11.51% decline year-over-year.
  • Gilead Sciences total assets for 2019 were $61.627B, a 3.22% decline from 2018.
  • Gilead Sciences total assets for 2018 were $63.675B, a 9.4% decline from 2017.
  • Gilead Sciences total assets for 2017 were $70.283B, a 23.35% increase from 2016.
  
Gilead Sciences Annual Total Assets
(Millions of US $)
2019 $61,627
2018 $63,675
2017 $70,283
2016 $56,977
2015 $51,716
2014 $34,664
2013 $22,579
2012 $21,240
2011 $17,303
2010 $11,593
2009 $9,699
2008 $6,937
2007 $5,835
2006 $4,086
2005 $3,766
Gilead Sciences Quarterly Total Assets
(Millions of US $)
2020-06-30 $55,934
2020-03-31 $59,741
2019-12-31 $61,627
2019-09-30 $59,146
2019-06-30 $63,210
2019-03-31 $62,837
2018-12-31 $63,675
2018-09-30 $64,305
2018-06-30 $65,355
2018-03-31 $65,381
2017-12-31 $70,283
2017-09-30 $64,662
2017-06-30 $60,263
2017-03-31 $57,701
2016-12-31 $56,977
2016-09-30 $56,609
2016-06-30 $49,980
2016-03-31 $47,765
2015-12-31 $51,716
2015-09-30 $50,637
2015-06-30 $39,167
2015-03-31 $38,321
2014-12-31 $34,664
2014-09-30 $28,844
2014-06-30 $31,206
2014-03-31 $28,078
2013-12-31 $22,579
2013-09-30 $22,468
2013-06-30 $22,624
2013-03-31 $22,212
2012-12-31 $21,240
2012-09-30 $20,964
2012-06-30 $20,502
2012-03-31 $19,950
2011-12-31 $17,303
2011-09-30 $12,640
2011-06-30 $12,694
2011-03-31 $12,987
2010-12-31 $11,593
2010-09-30 $11,456
2010-06-30 $10,497
2010-03-31 $10,696
2009-12-31 $9,699
2009-09-30 $8,937
2009-06-30 $8,387
2009-03-31 $7,520
2008-12-31 $6,937
2008-09-30 $6,974
2008-06-30 $6,517
2008-03-31 $5,879
2007-12-31 $5,835
2007-09-30 $5,318
2007-06-30 $4,826
2007-03-31 $4,615
2006-12-31 $4,086
2006-09-30 $5,299
2006-06-30 $5,180
2006-03-31 $4,037
2005-12-31 $3,766
2005-09-30 $2,919
2005-06-30 $2,688
2005-03-31 $2,369
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $75.487B $22.449B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $135.829B 10.46
Amgen (AMGN) United States $134.106B 14.57
CSL (CSLLY) Australia $95.578B 0.00
Regeneron Pharmaceuticals (REGN) United States $60.899B 23.29
Vertex Pharmaceuticals (VRTX) United States $55.058B 30.72
Illumina (ILMN) United States $46.406B 53.96
Biogen (BIIB) United States $42.572B 7.35
Seattle Genetics (SGEN) United States $34.401B 0.00
BeiGene (BGNE) Cayman Islands $27.423B 0.00
Moderna (MRNA) United States $26.978B 0.00
Alexion Pharmaceuticals (ALXN) United States $25.904B 10.79
Genmab (GMAB) Denmark $23.167B 14.62
Genmab (GNMSF) Denmark $21.854B 5.03
Immunomedics (IMMU) United States $20.299B 0.00
BioNTech SE (BNTX) Germany $19.848B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.638B 0.00
Incyte (INCY) United States $19.377B 0.00
Alnylam Pharmaceuticals (ALNY) United States $15.828B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.730B 71.14
Horizon Therapeutics Public (HZNP) Ireland $15.334B 35.88
Exact Sciences (EXAS) United States $14.958B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.055B 101.97
ARGENX SE-ADR (ARGX) Netherlands $12.072B 0.00
MyoKardia (MYOK) United States $11.788B 0.00
QIAGEN (QGEN) Netherlands $11.520B 29.24
Sarepta Therapeutics (SRPT) United States $10.776B 0.00
Bio-Techne Corp (TECH) United States $10.094B 69.26
Guardant Health (GH) United States $9.938B 0.00
Repligen (RGEN) United States $9.018B 143.13
Ascendis Pharma (ASND) Denmark $8.245B 0.00
Mirati Therapeutics (MRTX) United States $8.237B 0.00
Galapagos (GLPG) Belgium $8.043B 29.10
Exelixis (EXEL) United States $6.733B 24.48
CRISPR Therapeutics AG (CRSP) Switzerland $6.471B 200.48
ACADIA Pharmaceuticals (ACAD) United States $6.471B 0.00
Acceleron Pharma (XLRN) United States $6.393B 0.00
Adaptive Biotechnologies (ADPT) United States $6.375B 0.00
Novavax (NVAX) United States $5.586B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.571B 15.22
Blueprint Medicines (BPMC) United States $5.536B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.400B 0.00
Emergent Biosolutions (EBS) United States $4.924B 19.50
NeoGenomics (NEO) United States $4.652B 1404.33
Amicus Therapeutics (FOLD) United States $4.565B 0.00
China Biologic Products (CBPO) China $4.465B 26.50
Vir Biotechnology (VIR) United States $4.392B 0.00
Arena Pharmaceuticals (ARNA) United States $4.382B 0.00
Denali Therapeutics (DNLI) United States $4.203B 0.00
Halozyme Therapeutics (HALO) United States $4.119B 0.00
Fate Therapeutics (FATE) United States $3.861B 0.00
Twist Bioscience (TWST) United States $3.851B 0.00
Reata Pharmaceuticals (RETA) United States $3.841B 0.00
Insmed (INSM) United States $3.712B 0.00
Bluebird Bio (BLUE) United States $3.599B 0.00
MorphoSys AG (MOR) Germany $3.432B 44.98
Legend Biotech (LEGN) United States $3.421B 0.00
Global Blood Therapeutics (GBT) United States $3.412B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.394B 0.00
Eidos Therapeutics (EIDX) United States $2.811B 0.00
Alkermes (ALKS) Ireland $2.586B 54.20
I-Mab (IMAB) China $2.326B 0.00
PHARMA MAR SA (PHMMF) Spain $2.294B 0.00
Seres Therapeutics (MCRB) United States $2.150B 0.00
Sorrento Therapeutics (SRNE) United States $2.055B 0.00
Forma Therapeutics Holdings (FMTX) United States $2.029B 0.00
Editas Medicine (EDIT) United States $1.885B 0.00
Zymeworks (ZYME) Canada $1.855B 0.00
Amarin (AMRN) Ireland $1.846B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.817B 20.35
Inovio Pharmaceuticals (INO) United States $1.759B 0.00
UniQure (QURE) Netherlands $1.756B 0.00
Intra-Cellular Therapies (ITCI) United States $1.681B 0.00
Viela Bio (VIE) United States $1.657B 0.00
Revance Therapeutics (RVNC) United States $1.561B 0.00
Beam Therapeutics (BEAM) United States $1.536B 0.00
Zealand Pharma (ZEAL) Denmark $1.531B 0.00
Zealand Pharma (ZLDPF) Denmark $1.483B 0.00
Sangamo Therapeutics (SGMO) United States $1.462B 0.00
Northwest Biotherapeutics (NWBO) United States $1.461B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.418B 0.00
Intellia Therapeutics (NTLA) United States $1.380B 0.00
Epizyme (EPZM) United States $1.360B 0.00
Mesoblast (MESO) Australia $1.319B 0.00
Ligand Pharmaceuticals (LGND) United States $1.295B 43.78
Arcus Biosciences (RCUS) United States $1.266B 0.00
Mersana Therapeutics (MRSN) United States $1.224B 0.00
Coherus BioSciences (CHRS) United States $1.184B 6.90
Alcobra (ARCT) United States $1.153B 0.00
NGM Biopharmaceuticals (NGM) United States $1.141B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.114B 0.00
Cytokineticsorporated (CYTK) United States $1.107B 0.00
Heska (HSKA) United States $1.088B 0.00
Myriad Genetics (MYGN) United States $1.054B 0.00
Retrophin (RTRX) United States $1.049B 0.00
Genetron Holdings (GTH) China $1.021B 0.00
REGENXBIO (RGNX) United States $1.012B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.972B 0.00
Castle Biosciences (CSTL) United States $0.959B 0.00
Athenex (ATNX) United States $0.955B 0.00
Compugen (CGEN) Israel $0.954B 0.00
Adverum Biotechnologies (ADVM) United States $0.942B 0.00
Vericel (VCEL) United States $0.887B 0.00
Codexis (CDXS) United States $0.824B 0.00
NantKwest (NK) United States $0.822B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.811B 0.00
Pliant Therapeutics (PLRX) United States $0.810B 0.00
Morphic Holding (MORF) United States $0.803B 0.00
Arvinas (ARVN) United States $0.792B 0.00
Intrexon (PGEN) United States $0.772B 0.00
Alector (ALEC) United States $0.746B 0.00
Agenus (AGEN) United States $0.741B 0.00
Cellectis S.A (CLLS) France $0.726B 0.00
Protagonist Therapeutics (PTGX) United States $0.717B 0.00
MiMedx (MDXG) United States $0.712B 0.00
Frequency Therapeutics (FREQ) United States $0.709B 0.00
Pharming Group (PHGUF) Netherlands $0.692B 15.79
AnaptysBio (ANAB) United States $0.690B 0.00
Cara Therapeutics (CARA) United States $0.663B 0.00
Celldex Therapeutics (CLDX) United States $0.653B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Syndax Pharmaceuticals (SNDX) United States $0.603B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.589B 0.00
Kadmon Holdings (KDMN) United States $0.585B 0.00
VBI Vaccines (VBIV) United States $0.585B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.580B 0.00
Geron (GERN) United States $0.568B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.548B 4.79
IVERIC Bio (ISEE) United States $0.536B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.531B 0.00
Albireo Pharma (ALBO) United States $0.517B 0.00
Anika Therapeutics (ANIK) United States $0.509B 22.25
Cel-Sci (CVM) United States $0.494B 0.00
Clovis Oncology (CLVS) United States $0.484B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.484B 0.00
MeiraGTx Holdings (MGTX) United States $0.477B 0.00
Prothena (PRTA) Ireland $0.477B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.470B 0.00
MannKind (MNKD) United States $0.463B 0.00
Dynavax Technologies (DVAX) United States $0.457B 0.00
Avid Bioservices (CDMO) United States $0.452B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.448B 0.00
Amryt Pharma (AMYT) United Kingdom $0.433B 0.00
Sutro Biopharma (STRO) United States $0.432B 0.00
Starpharma Holdings (SPHRY) Australia $0.427B 0.00
Kala Pharmaceuticals (KALA) United States $0.426B 0.00
UROGEN PHARMA (URGN) United States $0.419B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.411B 0.00
Scholar Rock Holding (SRRK) United States $0.411B 0.00
Cue Biopharma (CUE) United States $0.390B 0.00
Forte Biosciences (FBRX) United States $0.378B 0.00
Merus (MRUS) Netherlands $0.375B 0.00
Puma Biotechnology (PBYI) United States $0.371B 0.00
Kamada (KMDA) Israel $0.370B 17.66
Xenon Pharmaceuticals (XENE) Canada $0.367B 0.00
Cellular Biomedicine (CBMG) United States $0.358B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.347B 0.00
Trevena (TRVN) United States $0.341B 0.00
IBio (IBIO) United States $0.341B 0.00
Precision BioSciences (DTIL) United States $0.340B 0.00
ANI Pharmaceuticals (ANIP) United States $0.336B 7.93
Bicycle Therapeutics (BCYC) United Kingdom $0.335B 0.00
Spero Therapeutics (SPRO) United States $0.334B 0.00
BioDelivery Sciences (BDSI) United States $0.330B 23.36
Syros Pharmaceuticals (SYRS) United States $0.330B 0.00
AC Immune SA (ACIU) Switzerland $0.321B 0.00
Athersys (ATHX) United States $0.318B 0.00
NextCure (NXTC) United States $0.313B 0.00
Innate Pharma S.A (IPHA) France $0.309B 0.00
ChromaDex (CDXC) United States $0.305B 0.00
CytomX Therapeutics (CTMX) United States $0.303B 0.00
WAVE Life Sciences (WVE) Singapore $0.299B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.297B 0.00
Cardiff Oncology (CRDF) United States $0.285B 0.00
Selecta Biosciences (SELB) United States $0.279B 0.00
PDL BioPharma (PDLI) United States $0.252B 0.00
Pluristem Therapeutics (PSTI) Israel $0.249B 0.00
Affimed (AFMD) Germany $0.249B 0.00
TELA Bio (TELA) United States $0.234B 0.00
Fortress Biotech (FBIO) United States $0.226B 0.00
Arbutus Biopharma (ABUS) United States $0.226B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.223B 0.00
XOMA (XOMA) United States $0.216B 0.00
HOOKIPA Pharma (HOOK) United States $0.212B 0.00
Verastem (VSTM) United States $0.207B 0.00
Dyadic (DYAI) United States $0.202B 0.00
Five Prime Therapeutics (FPRX) United States $0.201B 0.00
ADMA Biologics Inc (ADMA) United States $0.187B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.186B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
Aptinyx (APTX) United States $0.183B 0.00
Eton Pharmaceuticals (ETON) United States $0.183B 0.00
CorMedix Inc (CRMD) United States $0.175B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.173B 0.00
Cerecor (CERC) United States $0.172B 0.00
GENFIT S.A (GNFT) France $0.170B 0.00
Biofrontera AG (BFRA) Germany $0.167B 0.00
DBV Technologies S.A (DBVT) France $0.167B 0.00
Theratechnologies (THTX) Canada $0.163B 0.00
Kindred Biosciences (KIN) United States $0.159B 0.00
Liquidia Technologies (LQDA) United States $0.157B 0.00
VolitionRX (VNRX) United States $0.152B 0.00
Nicox SA (NICXF) France $0.149B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.149B 6.95
Exicure (XCUR) United States $0.147B 0.00
Bellus Health (BLU) Canada $0.146B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.146B 0.00
Checkpoint Therapeutics (CKPT) United States $0.142B 0.00
Prometic Life Sciences (LMNL) Canada $0.142B 0.00
SESEN BIO, INC (SESN) United States $0.139B 0.00
Applied Genetic Technologies (AGTC) United States $0.139B 0.00
AquaBounty Technologies (AQB) United States $0.129B 0.00
Cidara Therapeutics (CDTX) United States $0.128B 0.00
Aytu Bioscience (AYTU) United States $0.127B 0.00
Windtree Therapeutics (WINT) United States $0.126B 0.00
VTv Therapeutics (VTVT) United States $0.117B 0.00
Protalix BioTherapeutics (PLX) Israel $0.116B 0.00
Strongbridge Biopharma (SBBP) United States $0.115B 0.00
Celyad SA (CYAD) Belgium $0.114B 0.00
Lumos Pharma (LUMO) United States $0.114B 0.00
Unum Therapeutics (COGT) United States $0.114B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.113B 0.00
Catalyst Biosciences (CBIO) United States $0.111B 0.00
Orgenesis (ORGS) United States $0.110B 5.61
Gritstone Oncology (GRTS) United States $0.108B 0.00
Abeona Therapeutics (ABEO) United States $0.105B 0.00
AIT Therapeutics (XAIR) United States $0.103B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.103B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.101B 0.00
Antibe Therapeutics (ATBPF) Canada $0.101B 0.00
Oncobiologics (OTLK) United States $0.098B 0.00
Palatin Technologies (PTN) United States $0.096B 0.00
Enzo Biochem (ENZ) United States $0.095B 0.00
Cyclerion Therapeutics (CYCN) United States $0.088B 0.00
Ecology Coatings (ABVC) United States $0.086B 0.00
Evogene (EVGN) Israel $0.085B 0.00
ARAVIVE, INC (ARAV) United States $0.084B 0.00
DiaMedica Therapeutics (DMAC) United States $0.081B 0.00
Stealth BioTherapeutics (MITO) United States $0.076B 72.50
Idera Pharmaceuticals (IDRA) United States $0.074B 0.00
Bionano Genomics (BNGO) United States $0.073B 0.00
Prima BioMed (IMMP) Australia $0.072B 0.00
Organovo Holdings (ONVO) United States $0.071B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
Synlogic (SYBX) United States $0.069B 0.00
Adocia (ADOCY) France $0.067B 0.00
Appili Therapeutics (APLIF) Canada $0.067B 0.00
Clearside Biomedical (CLSD) United States $0.066B 0.00
AmpliPhi Biosciences (ARMP) United States $0.065B 0.00
Curis (CRIS) United States $0.063B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.063B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.061B 0.00
Proteostasis Therapeutics (PTI) United States $0.059B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.057B 0.00
Edesa Biotech (EDSA) Canada $0.057B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.054B 0.00
TRACON Pharmaceuticals (TCON) United States $0.051B 0.00
Soligenix (SNGX) United States $0.049B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Genetic Technologies (GENE) Australia $0.046B 0.00
Cocrystal Pharma (COCP) United States $0.046B 0.00
Acorda Therapeutics (ACOR) United States $0.045B 0.00
Novogen (KZIA) Australia $0.044B 0.00
Happiness Biotech Group (HAPP) China $0.043B 0.00
Pulmatrix (PULM) United States $0.042B 0.00
Cleveland BioLabs (CBLI) United States $0.041B 0.00
IMMURON (IMRN) Australia $0.040B 0.00
CollPlant Holdings (CLGN) Israel $0.038B 0.00
AnPac Bio-Medical Science (ANPC) China $0.038B 0.00
Chanticleer Holdings (SONN) United States $0.038B 0.00
Vaccinex (VCNX) United States $0.037B 0.00
Apricus Biosciences (SEEL) United States $0.035B 0.00
OvaScience (MLND) United States $0.034B 0.00
Advaxis (ADXS) United States $0.034B 0.00
ATyr Pharma (LIFE) United States $0.033B 0.00
Signal Genetics (MGEN) United States $0.028B 0.00
BioCardia (BCDA) United States $0.028B 0.00
Prana Biotechnology (ATHE) Australia $0.027B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.024B 0.00
Alimera Sciences (ALIM) United States $0.023B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
Aptevo Therapeutics (APVO) United States $0.023B 0.00
Celsion (CLSN) United States $0.021B 0.00
Spherix (AIKI) United States $0.021B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
BioPharmX (TMBR) United States $0.018B 0.00
Cesca Therapeutics (THMO) United States $0.018B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Titan Pharmaceuticals (TTNP) United States $0.012B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
GeoVax Labs (GOVX) United States $0.002B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00